Response to the Letter to the Editor Entitled "Additive Obinutuzumab Achieves High Remission Rates in Rituximab-Refractory Membranous Nephropathy: Caution in effect Attribution". (PubMed, Am J Nephrol) - Oct 13, 2026 - No abstract available
Journal • Glomerulonephritis • Renal Disease
|